PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION

Bibliographic Details
Main Author: BELOTTO,Marcos
Publication Date: 2019
Other Authors: CROUZILLARD,Bruna do Nascimento Santos, ARAUJO,Karla de Oliveira, PEIXOTO,Renata D’Alpino
Format: Article
Language: eng
Source: ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000100502
Summary: ABSTRACT Introduction: Pancreatic neuroendocrine tumors (pNET) correspond to about 3% of all tumors in pancreas and could be presented as a difficult diagnosis and management. Objective: To review the diagnosis and treatment of the pNET available in scientific literature. Method: A bibliographic survey was performed by means of an online survey of MeSH terms in the Pubmed database. A total of 104 articles were published in the last 15 years, of which 23 were selected as the basis for the writing of this article. Results: pNET is an infrequent neoplasia and their incidence, in USA, is about 1:100.000 inhabitants/year. Thereabout 30% of them produce hormones presenting as a symptomatic disease and others 70% of the cases could be silent disease. Magnetic Resonance Imaging (MRI) and/or Computed Tomography (CT) have similar sensitivy to detect pNET. They are very important when associated to nuclear medicine mainly Positron Emission Tomography (PET-CT) Gallium-68 to find primary tumor and its staging. The appropriate treatment should be chosen based on characteristics of the tumor, its staging and associated comorbidities. Conclusion: The surgical resection is still the best treatment for patients with ressectable pancreatic NETs. However, the size, grade, tumor functionality, stage and association with multiple endocrine neoplasia type 1 (MEN-1) are important to define who will be eligible for surgical treatment. In general, tumors bigger than 2 cm are eligible for surgical treatment, except insulinomas whose surgical resection is recommended no matter the size.
id CBCD-1_5c89eec9bcc0e1e75ca34f2d3d240d76
oai_identifier_str oai:scielo:S0102-67202019000100502
network_acronym_str CBCD-1
network_name_str ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
repository_id_str
spelling PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTIONNeuroendocrine tumorPancreatic neoplasmPancreasABSTRACT Introduction: Pancreatic neuroendocrine tumors (pNET) correspond to about 3% of all tumors in pancreas and could be presented as a difficult diagnosis and management. Objective: To review the diagnosis and treatment of the pNET available in scientific literature. Method: A bibliographic survey was performed by means of an online survey of MeSH terms in the Pubmed database. A total of 104 articles were published in the last 15 years, of which 23 were selected as the basis for the writing of this article. Results: pNET is an infrequent neoplasia and their incidence, in USA, is about 1:100.000 inhabitants/year. Thereabout 30% of them produce hormones presenting as a symptomatic disease and others 70% of the cases could be silent disease. Magnetic Resonance Imaging (MRI) and/or Computed Tomography (CT) have similar sensitivy to detect pNET. They are very important when associated to nuclear medicine mainly Positron Emission Tomography (PET-CT) Gallium-68 to find primary tumor and its staging. The appropriate treatment should be chosen based on characteristics of the tumor, its staging and associated comorbidities. Conclusion: The surgical resection is still the best treatment for patients with ressectable pancreatic NETs. However, the size, grade, tumor functionality, stage and association with multiple endocrine neoplasia type 1 (MEN-1) are important to define who will be eligible for surgical treatment. In general, tumors bigger than 2 cm are eligible for surgical treatment, except insulinomas whose surgical resection is recommended no matter the size.Colégio Brasileiro de Cirurgia Digestiva2019-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000100502ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) v.32 n.1 2019reponame:ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)instname:Colégio Brasileiro de Cirurgia Digestiva (CBCD)instacron:CBCD10.1590/0102-672020180001e1428info:eu-repo/semantics/openAccessBELOTTO,MarcosCROUZILLARD,Bruna do Nascimento SantosARAUJO,Karla de OliveiraPEIXOTO,Renata D’Alpinoeng2019-02-05T00:00:00Zoai:scielo:S0102-67202019000100502Revistahttp://abarriguda.org.br/revista/index.php/revistaabarrigudaarepb/indexONGhttps://old.scielo.br/oai/scielo-oai.php||revistaabcd@gmail.com2317-63262317-6326opendoar:2019-02-05T00:00ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) - Colégio Brasileiro de Cirurgia Digestiva (CBCD)false
dc.title.none.fl_str_mv PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
title PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
spellingShingle PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
BELOTTO,Marcos
Neuroendocrine tumor
Pancreatic neoplasm
Pancreas
title_short PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
title_full PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
title_fullStr PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
title_full_unstemmed PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
title_sort PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
author BELOTTO,Marcos
author_facet BELOTTO,Marcos
CROUZILLARD,Bruna do Nascimento Santos
ARAUJO,Karla de Oliveira
PEIXOTO,Renata D’Alpino
author_role author
author2 CROUZILLARD,Bruna do Nascimento Santos
ARAUJO,Karla de Oliveira
PEIXOTO,Renata D’Alpino
author2_role author
author
author
dc.contributor.author.fl_str_mv BELOTTO,Marcos
CROUZILLARD,Bruna do Nascimento Santos
ARAUJO,Karla de Oliveira
PEIXOTO,Renata D’Alpino
dc.subject.por.fl_str_mv Neuroendocrine tumor
Pancreatic neoplasm
Pancreas
topic Neuroendocrine tumor
Pancreatic neoplasm
Pancreas
description ABSTRACT Introduction: Pancreatic neuroendocrine tumors (pNET) correspond to about 3% of all tumors in pancreas and could be presented as a difficult diagnosis and management. Objective: To review the diagnosis and treatment of the pNET available in scientific literature. Method: A bibliographic survey was performed by means of an online survey of MeSH terms in the Pubmed database. A total of 104 articles were published in the last 15 years, of which 23 were selected as the basis for the writing of this article. Results: pNET is an infrequent neoplasia and their incidence, in USA, is about 1:100.000 inhabitants/year. Thereabout 30% of them produce hormones presenting as a symptomatic disease and others 70% of the cases could be silent disease. Magnetic Resonance Imaging (MRI) and/or Computed Tomography (CT) have similar sensitivy to detect pNET. They are very important when associated to nuclear medicine mainly Positron Emission Tomography (PET-CT) Gallium-68 to find primary tumor and its staging. The appropriate treatment should be chosen based on characteristics of the tumor, its staging and associated comorbidities. Conclusion: The surgical resection is still the best treatment for patients with ressectable pancreatic NETs. However, the size, grade, tumor functionality, stage and association with multiple endocrine neoplasia type 1 (MEN-1) are important to define who will be eligible for surgical treatment. In general, tumors bigger than 2 cm are eligible for surgical treatment, except insulinomas whose surgical resection is recommended no matter the size.
publishDate 2019
dc.date.none.fl_str_mv 2019-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000100502
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000100502
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0102-672020180001e1428
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Colégio Brasileiro de Cirurgia Digestiva
publisher.none.fl_str_mv Colégio Brasileiro de Cirurgia Digestiva
dc.source.none.fl_str_mv ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) v.32 n.1 2019
reponame:ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
instname:Colégio Brasileiro de Cirurgia Digestiva (CBCD)
instacron:CBCD
instname_str Colégio Brasileiro de Cirurgia Digestiva (CBCD)
instacron_str CBCD
institution CBCD
reponame_str ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
collection ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
repository.name.fl_str_mv ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) - Colégio Brasileiro de Cirurgia Digestiva (CBCD)
repository.mail.fl_str_mv ||revistaabcd@gmail.com
_version_ 1754208958658117632